![Hans Rainer Künzle](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hans Rainer Künzle
Director/Board Member at KENDRIS AG
Profile
Hans Rainer Künzle is currently a Member-Supervisory Board at KENDRIS AG since 2005.
He was previously the President & Director at EraCal Therapeutics AG.
Hans Rainer Künzle active positions
Companies | Position | Start |
---|---|---|
KENDRIS AG
![]() KENDRIS AG Investment Trusts/Mutual FundsMiscellaneous KENDRIS AG provides family office, trust, and fiduciary services. It also offers Swiss and international tax and legal advice, family office services, compliance, finance and accounting, outsourcing and art management services. The company was founded in 1999 and is headquartered in Zurich, Switzerland. | Director/Board Member | 2004-12-31 |
Former positions of Hans Rainer Künzle
Companies | Position | End |
---|---|---|
EraCal Therapeutics AG
![]() EraCal Therapeutics AG Miscellaneous Commercial ServicesCommercial Services EraCal Therapeutics AG operates as a preclinical biotech company. The firm engages in researching and developing biotechnology. The company was founded by Joshua Jordi in September 2018 and is headquartered in Zollikon, Switzerland. | President | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
KENDRIS AG
![]() KENDRIS AG Investment Trusts/Mutual FundsMiscellaneous KENDRIS AG provides family office, trust, and fiduciary services. It also offers Swiss and international tax and legal advice, family office services, compliance, finance and accounting, outsourcing and art management services. The company was founded in 1999 and is headquartered in Zurich, Switzerland. | Miscellaneous |
EraCal Therapeutics AG
![]() EraCal Therapeutics AG Miscellaneous Commercial ServicesCommercial Services EraCal Therapeutics AG operates as a preclinical biotech company. The firm engages in researching and developing biotechnology. The company was founded by Joshua Jordi in September 2018 and is headquartered in Zollikon, Switzerland. | Commercial Services |
- Stock Market
- Insiders
- Hans Rainer Künzle